Poland· PL-100107752
Immunine 1200 IU
A coagulation factor ix product containing factor ix coagulationis humanus, registered in Poland by Takeda Pharma Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Coagulation factor ix is registered in 12 of 19 countries.
Countries holding a registration under ATC B02BD04 (coagulation factor ix), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Coagulation factor ix · ATC B02BD04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Factor IX coagulationis humanus
- Manufacturer
- Takeda Pharma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- B02BD04
- ATC class
- Coagulation factor IX
- Defined daily dose
- 600 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990645220
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for coagulation factor ix.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor ix · interactions on record
3 records
- 2 severe
- 1 moderate
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- PegvaliaseA16AB19moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Coagulation factor ix in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad7d802f-ff20-4b99-a555-0aaf2fe4ab98 GET /v1/drugs/ad7d802f-ff20-4b99-a555-0aaf2fe4ab98?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek i rozpuszczalnik do sporządzania roztworu do wstrzykiwań lub infuzji",
"source": "urpl",
"strength": "1200 j.m.",
"packaging": "05909990645220 ¦ Rp ¦ 43343\n1 fiol. 1200 j.m. Proszek IMMUNINE ¦ 1 igła dwustronna ¦ 1 igła jednorazowego użytku ¦ 1 fiol. 10 ml rozpuszczalnik ¦ 1 igła z filtrem ¦ 1 igła odpowietrzająca ¦ 1 zestaw do infuzji ¦ 1 strzykawka jednorazowego użytku (10 ml)",
"substance": "Factor IX coagulationis humanus 1200 j.m.",
"common_name": "Factor IX coagulationis humanus",
"pl_product_id": "100107752",
"pozwolenie_nr": "14615",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about coagulation factor ix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.